Back to Search
SEEMA KUMAR, M.D.
M.D.
Pediatric Endocrinology Physician
NPI: 1417929894Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism Physician
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
41964(MN)
Pediatrics Physician
Pediatrics
Code: 208000000X
41964(MN)
Pediatric Endocrinology PhysicianPrimary
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
49164(MN)41964(MN)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
PMID 19561323·Blood·2009
8-other
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
PMID 18429054·Am J Hematol·2008
8-other
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
PMID 18288560·Clin Exp Nephrol·2008
5-case
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
PMID 18804043·Biol Blood Marrow Transplant·2008
4-observational
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
PMID 18332915·Bone Marrow Transplant·2008
4-observational
Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
PMID 18315995·Mayo Clin Proc·2008
4-observational
Impact of early relapse after auto-SCT for multiple myeloma.
PMID 18587435·Bone Marrow Transplant·2008
4-observational
Impact of additional cytoreduction following autologous SCT in multiple myeloma.
PMID 18560409·Bone Marrow Transplant·2008
8-other
Improved survival in multiple myeloma and the impact of novel therapies.
PMID 17975015·Blood·2008
8-other
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
PMID 18318761·Br J Haematol·2008
3-trial
Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
PMID 17680019·Bone Marrow Transplant·2007
6-review
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.
PMID 17581613·Leukemia·2007
3-trial
Thalidomide and lenalidomide in the treatment of multiple myeloma.
PMID 16750621·Eur J Cancer·2006
6-review
Duodenal diverticulosis in autosomal dominant polycystic kidney disease.
PMID 16951424·Nephrol Dial Transplant·2006
5-case
FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myeloma.
PMID 16487170·Br J Haematol·2006
8-other
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
PMID 16110026·J Clin Oncol·2005
8-other
Thalidomide and dexamethasone: therapy for multiple myeloma.
PMID 16221046·Expert Rev Anticancer Ther·2005
6-review
Drug insight: thalidomide as a treatment for multiple myeloma.
PMID 16264962·Nat Clin Pract Oncol·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1417929894
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile